Altre lingue U.S. Stem Cell, Inc.

Azioni

USRM

US90350U1007

Mercato chiuso - OTC Markets Altri mercati azionari 21:46:59 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,0001 ^USD	0,00%		0,00%	0,00%

2023	U.S. Stem Cell, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2022	CI
2023	U.S. Stem Cell, Inc. Il revisore dei conti solleva dubbi sulla continuità aziendale	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	14/04/23
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	14/04/23
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	09/11/22
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22
U.S. STEM CELL, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	08/07/22
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	23/05/22
U.S. Stem Cell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	31/03/22
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	31/03/22
U S Stem Cell : Material Event - Form 8-K/A	09/03/22
U.S. STEM CELL, INC. Other Events (form 8-K/A)	09/03/22
U S Stem Cell : Mark Borman appointed Chairman of the Board of USRM	09/03/22
U.S. STEM CELL, INC. : Other Events (form 8-K)	09/03/22
U.S. Stem Cell, Inc. Announces Management Changes	09/03/22
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	09/11/21
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09/11/21
U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation	18/10/21
U S Stem Cell : NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	12/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue U.S. Stem Cell, Inc.

Azioni

USRM

US90350U1007

Altre lingue

Filtri